News

November 26, 2019

Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors.


Tel Aviv, Israel, November 26, 2019 – Alpha Tau Medical is pleased to announce the publication of the results of its first clinical trial of Alpha DaRT™, a...

September 5, 2018

Proceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for the company's breakthrough cancer treatment, Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy).

TEL AVIV, Israel, -- Alpha Tau M...

August 22, 2018

Alpha Tau is in the last stages of raising an investment of several tens of millions of dollars.

Israeli oncology company Alpha Tau Medical Ltd. is in the last stages of raising an investment of several tens of millions of dollars, one person familiar with the matter to...

July 17, 2017

Following the promising preliminary clinical results, showing the ability of Alpha DaRT to effectively and safely destroy solid tumors, Alpha Tau Medical raises more capital than planned.

Alpha Tau Medical Ltd. has raised 20% more capital than planned for its Alpha DaRT...

Please reload

Categories
Please reload

Sign up
Featured Posts

I'm busy working on my blog posts. Watch this space!

Please reload

Archive
Please reload

Follow Us
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon

CONTACT US

Are you looking to participate in clinical trials?

Take our self-assessment test to find potentially suitable studies.

For other inquiries, please visit our contact page.